ArticleMalaria journal2026
Cerebral malaria caused by Plasmodium vivax in an afrodescendant adult in Colombia: case report.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria, caused by parasites of the Plasmodium genus and transmitted by Anopheles mosquitoes, remains a global public health issue, with a high incidence in tropical and subtropical regions. Although Plasmodium falciparum is the main cause of severe cases, Plasmodium vivax can also lead to serious complications, including cerebral malaria. CASE PRESENTATION: This case report presents the case of a 43-year-old woman from the southwestern Pacific coast, Colombia, who developed severe neurological symptoms with an initially unclear diagnosis. A thick blood smear confirmed P. vivax infection. She was treated with intravenous artesunate and subsequently with chloroquine and primaquine, and she achieved a full recovery.
conclusionsCerebral malaria has traditionally been associated with P. falciparum, P. vivax can also cause it through mechanical and inflammatory mechanisms, with a complex pathophysiology and potentially fatal outcomes. Early treatment with parenteral artesunate and intensive supportive care is key to improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.